KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Raw Materials (2018 - 2025)

Historic Raw Materials for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $24.7 million.

  • Twist Bioscience's Raw Materials rose 5386.44% to $24.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $24.7 million, marking a year-over-year increase of 5386.44%. This contributed to the annual value of $20.2 million for FY2025, which is 1660.31% up from last year.
  • Twist Bioscience's Raw Materials amounted to $24.7 million in Q4 2025, which was up 5386.44% from $20.2 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Raw Materials ranged from a high of $33.6 million in Q1 2023 and a low of $11.4 million during Q1 2021
  • For the 5-year period, Twist Bioscience's Raw Materials averaged around $23.5 million, with its median value being $22.9 million (2023).
  • As far as peak fluctuations go, Twist Bioscience's Raw Materials surged by 20519.11% in 2021, and later plummeted by 3592.36% in 2024.
  • Quarter analysis of 5 years shows Twist Bioscience's Raw Materials stood at $30.3 million in 2021, then rose by 10.62% to $33.6 million in 2022, then decreased by 29.22% to $23.8 million in 2023, then tumbled by 32.51% to $16.0 million in 2024, then surged by 53.86% to $24.7 million in 2025.
  • Its last three reported values are $24.7 million in Q4 2025, $20.2 million for Q3 2025, and $17.5 million during Q2 2025.